A new gene editing service provides researchers on campus with genetically engineered pluripotent stem cell lines derived using CRISPR-Cas9. The UW-Madison iPSC Reprogramming and Human Stem Cell Gene Editing Service is co-operated by the Waisman Center’s iPSC Core and led by investigators Anita Bhattacharyya and Su-Chun Zhang.
The techniques and expertise that keep the service running at maximum capacity have driven demand for their stem cell lines so high that the project may need to expand, explains Bhattacharyya.
“Our goal is to provide the technology — we make the human stem cell lines that people want — so that the labs can focus on addressing the underlying scientific questions,” says Bhattacharyya.
Read more about how the two frontiers of science are colliding to spark innovation here: